Aurobindo will shell out $250 million to acquire drugmaker Lannett, shoring up the Indian drugmaker’s footprint in the U.S.

Aurobindo Pharma to acquire US-based Lannett for $250M, gaining a strategic local manufacturing base to offset tariffs and ...

Aurobindo Pharma USA will acquire Lannett from Lannett Seller Holdco for $250 million on a cash-free, debt-free basis.

Aurobindo Pharma USA acquires Lannett Company LLC for $250 million, expanding U.S. manufacturing capabilities and product ...

Lannett is selling its liquid drug manufacturing facility in Carmel, N.Y., as well as equipment located at the facility, certain ANDAs and other assets to a private company for $10.5 million in ...

Lannett has been focused on paying down debt, which will increase EPS and free up future earnings for further debt payments. Nothing has stuck so far from the price fixing allegations over the ...

Lannett is both a developer and manufacturer of generic pharmaceutical products in a variety of forms. After marked expansion from 2005-2010, the company also obtained its own distribution ...

PHILADELPHIA (AP) _ Lannett Co. (LCI) on Wednesday reported a fiscal third-quarter loss of $16.6 million, after reporting a profit in the same period a year earlier. The Philadelphia-based company ...

Shares of Lannett plunged by 12.9% on Monday after the Food & Drug Administration said it planned to withdraw approval of its generic treatment for attention deficit hyperactivity disorder. The ...

Generic Drugmaker Lannett Hires CFO Amid Industry Headwinds Longtime finance chief of Philadelphia-based company to retire in August By Mark Maurer Aug. 1, 2019 7:04 pm ET ...

Generic drug maker and distributor Lannett Co. Inc.’s shares tanked on Monday, after the company announced the loss of a major customer and issued a profit warning for its fiscal fourth quarter.